subject: CHEMBL.COMPOUND:CHEMBL3544907

subject_name: PICOPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3544907

object_name: colorectal carcinoma

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL3544907

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Burn injury


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Ph-positive acute lymphoblastic leukemia

tested_intervention: yes


subject: CHEBI:78543

object_name: adult acute lymphoblastic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4298207

subject_name: ZILUCOPLAN

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:229659

subject_name: Zilucoplan


subject: CHEBI:135948

subject_name: Amifampridine

object_name: Lambert-Eaton myasthenic syndrome


subject: UNII:D07V79Q44T

object_name: nonpapillary renal cell carcinoma


subject: UNII:D07V79Q44T

object_name: clear cell renal carcinoma


subject: UNII:D07V79Q44T

object_name: renal cell adenocarcinoma


subject: UNII:D07V79Q44T

object_name: renal cell carcinoma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: periodontitis


subject: CHEBI:51254

object_name: periodontal disorder


subject: CHEBI:51254

object_name: Periodontal Pocket


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR

object_name: autosomal dominant polycystic kidney disease


subject: PUBCHEM.COMPOUND:3043660


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: adult hepatocellular carcinoma


subject: CHEBI:5801

object_name: liver cancer


subject: CHEBI:5801

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:5801

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C1328149


subject: UNII:BIW199E18V

subject_name: Relamorelin

object_name: gastroparesis


subject: UNII:BIW199E18V

object_name: Gastroparesis, CTCAE


subject: UNII:BIW199E18V

object_name: diabetes mellitus


subject: UMLS:C4045486

subject_name: relamorelin


subject: UMLS:C4045486


subject: UMLS:C4045486


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Gastrointestinal dysfunction


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: carcinoma of esophagus


subject: CHEBI:4466

object_name: esophageal cancer


subject: CHEBI:4466

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:4466

object_name: neoplasm of esophagus


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: Multiple sclerosis relapse


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Vogt-Koyanagi-Harada disease


subject: CHEBI:233310

subject_name: Mubritinib

object_name: pancreatic neoplasm


subject: CHEBI:233310

object_name: malignant pancreatic neoplasm


subject: CHEBI:233310

object_name: ovarian cancer


subject: CHEBI:233310

object_name: ovarian neoplasm


subject: CHEBI:233310

object_name: breast neoplasm


subject: CHEBI:233310

object_name: kidney neoplasm


subject: CHEBI:233310

object_name: lung cancer


subject: CHEBI:233310

object_name: lung neoplasm


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: type 1 diabetes mellitus 1


subject: UMLS:C3854029

object_name: type 1 diabetes mellitus


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:44602504

object_name: inflammatory bowel disease 1


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Incontinence


subject: CHEBI:41879

object_name: Finding relating to sexuality and sexual activity


subject: CHEBI:41879

object_name: Inflammatory Response


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C1831906

object_name: chronic hepatitis C virus infection


subject: UNII:9UKQ1NQ8YX

object_name: bipolar disorder


subject: UNII:28PGH5X4OQ


subject: UMLS:C3529989


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:9821941

object_name: schizoaffective disorder


subject: GTOPDB:13633

subject_name: edifoligide

object_name: end stage renal failure


subject: GTOPDB:13633

object_name: chronic kidney disease


subject: GTOPDB:13633

object_name: Chronic uremia


subject: GTOPDB:13633

object_name: hyperplasia


subject: GTOPDB:13633

object_name: Hyperplasia of the endometrium


subject: CHEMBL.COMPOUND:CHEMBL2108316

subject_name: EDIFOLIGIDE


subject: CHEMBL.COMPOUND:CHEMBL2108316


subject: CHEMBL.COMPOUND:CHEMBL2108316


subject: CHEMBL.COMPOUND:CHEMBL2108316


subject: CHEMBL.COMPOUND:CHEMBL2108316


subject: PUBCHEM.COMPOUND:85364156

object_name: gastroparesis


subject: PUBCHEM.COMPOUND:85364156

object_name: Gastroparesis, CTCAE


subject: PUBCHEM.COMPOUND:85364156

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:85364156

object_name: Complications of Diabetes Mellitus


subject: UMLS:C3886758


subject: UMLS:C3886758


subject: UMLS:C3886758


subject: UMLS:C3886758


subject: UNII:169D1260KM

subject_name: NITROPRUSSIDE

object_name: hypotension


subject: UNII:169D1260KM

object_name: Hypotension, CTCAE


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: infective endocarditis


subject: UMLS:C0279328

object_name: subacute bacterial endocarditis


subject: CHEBI:3535

subject_name: Cephalexin

object_name: Surgical Wound Infection


subject: CHEBI:3534


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: alopecia areata


subject: CHEBI:229233

object_name: alopecia


subject: UNII:YUN2306954

subject_name: Cilofexor


subject: UNII:XE10NJQ95M

subject_name: Firsocostat


subject: PR:000013491

subject_name: poly(U)-binding-splicing factor PUF60


subject: PR:000007344

subject_name: FERM, ARHGEF and pleckstrin domain-containing protein 2


subject: CHEBI:167574

subject_name: Semaglutide


subject: PR:000014616


subject: UniProtKB:Q62177

subject_name: SEM3B_MOUSE Semaphorin-3B (sprot)


subject: CHEBI:63610

subject_name: Misoprostol

object_name: post term pregnancy


subject: CHEBI:63610

object_name: oligohydramnios


subject: CHEBI:63610

object_name: preeclampsia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: hematologic disorder


subject: UMLS:C0085297

object_name: blood disease


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: breast neoplasm


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:2269

object_name: Eye Infections, Bacterial


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: GTOPDB:13305

subject_name: linvoseltamab

object_name: plasma cell myeloma


subject: UNII:M3CPC50MZS

subject_name: LINVOSELTAMAB


subject: CHEBI:31413

subject_name: Clobazam

object_name: epilepsy


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: lung neoplasm


subject: UMLS:C5783929

subject_name: FGFR3 Inhibitor TYRA-300

object_name: FGFR3 Gene Alteration Positive


subject: UMLS:C5783929

object_name: Metastatic urothelial carcinoma


subject: UMLS:C5783929

object_name: Childhood Solid Neoplasm


subject: UMLS:C5783929

object_name: Adult Solid Neoplasm


subject: UMLS:C5783929

object_name: Solid Neoplasm


subject: UMLS:C5783929

object_name: urothelial carcinoma


subject: UMLS:C5783929

object_name: transitional cell carcinoma


subject: UMLS:C5783929

object_name: Advanced Urothelial Carcinoma


subject: UMLS:C5783929

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C5783929

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5783929

object_name: carcinoma of urinary tract


subject: UMLS:C5783929

object_name: malignant urinary system neoplasm


subject: UMLS:C5783929

object_name: urinary system neoplasm


subject: UMLS:C5783929

object_name: bladder tumor


subject: UMLS:C5783929

object_name: urinary bladder carcinoma


subject: UMLS:C5783929

object_name: urinary bladder cancer


subject: UMLS:C5783929

object_name: childhood bladder carcinoma


subject: UMLS:C5783929

object_name: FGFR3 gene mutation


subject: UMLS:C5783929

object_name: superficial urinary bladder carcinoma


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Atrophy of alveolar ridges


subject: CHEBI:41879

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: psoriatic arthritis


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Metastatic non-small cell lung cancer


subject: UNII:K16AIQ8CTM

object_name: ERBB2 Gene Mutation


subject: UNII:K16AIQ8CTM

object_name: Non-small cell lung cancer stage III


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:50733

subject_name: nutraceutical

object_name: irritable bowel syndrome


subject: CHEBI:50733

object_name: Functional abdominal pain syndrome


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: type 2 diabetes mellitus


subject: CHEBI:91464

object_name: leukemia


subject: CHEBI:91464

object_name: childhood leukemia


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: UMLS:C0915830


subject: UMLS:C0915830


subject: GTOPDB:4985

object_name: type 1 diabetes mellitus 1


subject: GTOPDB:4985

object_name: type 1 diabetes mellitus


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9150

subject_name: Simvastatin

object_name: cardiovascular disorder


subject: CHEBI:9150

object_name: hyperlipidemia


subject: CHEBI:9150

object_name: hyperlipoproteinemia


subject: CHEBI:9150

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:9150

object_name: Serum lipids high (finding)


subject: UMLS:C5241873

subject_name: peanut protein

object_name: Allergy


subject: UMLS:C5241873

object_name: History of allergies


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Decreased cardiac output


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:15365

subject_name: Aspirin

object_name: anterior ischemic optic neuropathy


subject: CHEBI:73611

subject_name: Met-Gly

object_name: non-small cell lung carcinoma


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: MESH:C000730036

object_name: sickle cell disease


subject: CHEBI:50858

subject_name: corticosteroid

object_name: epilepsy


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: CHEBI:2704

subject_name: Anastrozole

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:2704

object_name: metabolic syndrome X


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C2348756


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UNII:8BC08N1MS5

object_name: schizophrenia


subject: UMLS:C1831975

object_name: prostate carcinoma


subject: UMLS:C1831975

object_name: prostate cancer


subject: UNII:CGA81G3KR5

subject_name: PUCOTENLIMAB

object_name: Adult Rhabdomyosarcoma


subject: UNII:CGA81G3KR5

object_name: rhabdomyosarcoma


subject: UNII:CGA81G3KR5

object_name: Childhood Rhabdomyosarcoma


subject: UNII:CGA81G3KR5

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:CGA81G3KR5

object_name: childhood malignant neoplasm


subject: UMLS:C5205493

subject_name: Pucotenlimab


subject: UMLS:C5205493


subject: UMLS:C5205493


subject: UMLS:C5205493


subject: UMLS:C5205493


subject: CHEBI:135720

subject_name: Deflazacort

object_name: Impacted third molar tooth


subject: CHEBI:73589

subject_name: Leu-Thr

object_name: diarrhea


subject: CHEBI:73589

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:73589

object_name: Diarrhea, CTCAE


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: motion sickness


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: Advanced breast cancer


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UMLS:C0673472

object_name: Parkinson disease


subject: CHEBI:134726

subject_name: Istradefylline


subject: CHEBI:50692

subject_name: Mifepristone

object_name: abortion in second trimester


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:61080

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:61080

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:61080

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:61080

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:61080

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:61080

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:3757

subject_name: Clonidine

object_name: male reproductive organ cancer


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:60802

subject_name: ropivacaine


subject: UMLS:C0148405

subject_name: Vinegar

object_name: type 2 diabetes mellitus


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: diabetic neuropathy


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: peripheral vascular disease


subject: CHEBI:63005

object_name: peripheral arterial disease


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C0971731


subject: CHEBI:4672

subject_name: Docetaxel


subject: UNII:60ES45KTMK

subject_name: Pilaralisib

object_name: cancer


subject: UMLS:C3657458


subject: CHEBI:74705

subject_name: Met-Leu

object_name: migraine


subject: CHEBI:74705

object_name: migraine with or without aura, susceptibility to, 1


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:33353

subject_name: technetium atom

object_name: eosinophilic esophagitis


subject: CHEBI:33353

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C4505505

object_name: neuralgia


subject: UMLS:C4505505

object_name: Neuropathic pain


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:16494

subject_name: thioctic acid

object_name: type 1 diabetes mellitus


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:63115

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:63115

object_name: anaplastic astrocytoma


subject: CHEBI:63115

object_name: glioblastoma


subject: CHEBI:63115

object_name: Childhood Glioblastoma


subject: CHEBI:63115

object_name: adult glioblastoma


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor

object_name: non-small cell lung carcinoma


subject: UMLS:C5574906

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C5574906

object_name: lung cancer


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:PVI5M0M1GW

object_name: amyotrophic lateral sclerosis


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:164718816

subject_name: neladalkib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:164718816

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:J32P26A6BC

subject_name: NELADALKIB


subject: UNII:J32P26A6BC


subject: DRUGBANK:DB18682


subject: DRUGBANK:DB18682


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:PQX0D8J21J

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Rectal cancer stage IV


subject: UNII:PQX0D8J21J

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:PQX0D8J21J

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage III Colon Cancer


subject: UNII:PQX0D8J21J

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:PQX0D8J21J

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:73350

subject_name: Ala-Gly-Ser

object_name: bronchitis


subject: CHEBI:73350

object_name: Acute bronchitis


subject: PR:000022126

subject_name: amino-acid acetyltransferase


subject: PR:000022126


subject: PR:000008015

subject_name: alpha-galactosidase A


subject: PR:000008015


subject: UniProtKB:P51569

subject_name: AGAL_MOUSE Alpha-galactosidase A (sprot)


subject: UniProtKB:P51569


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: neuroendocrine neoplasm


subject: UMLS:C3898831

object_name: High grade neuroendocrine carcinoma, any site


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: Rectal cancer stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:31431

object_name: glioblastoma


subject: CHEBI:31431

object_name: Brain Stem Glioblastoma


subject: CHEBI:31431

object_name: glioma susceptibility 1


subject: CHEBI:31431

object_name: Childhood Glioblastoma


subject: CHEBI:31431

object_name: adult glioblastoma


subject: CHEBI:173763

subject_name: Thermophillin


subject: CHEBI:173763


subject: CHEBI:173763


subject: CHEBI:173763


subject: CHEBI:173763


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: PUBCHEM.COMPOUND:23597337


subject: PUBCHEM.COMPOUND:23597337


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:4659


subject: CHEBI:4659


subject: CHEBI:4659


subject: CHEBI:27470

subject_name: Folic acid

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:16822

subject_name: choline sulfate


subject: CHEBI:15354

subject_name: Choline


subject: UNII:B04Z1JB2HS

object_name: dental caries


subject: UNII:B04Z1JB2HS

object_name: Dental Caries, CTCAE


subject: UMLS:C1328655

object_name: colon carcinoma


subject: UMLS:C1328655

object_name: colorectal cancer


subject: UMLS:C1328655

object_name: colon cancer


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: CHEBI:31550


subject: UMLS:C5666949

subject_name: Anti-CD47/Anti-HER2 Bispecific Antibody IMM2902

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5666949

object_name: Advanced breast cancer


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Barrett esophagus


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C4086907

object_name: metastatic melanoma


subject: CHEBI:8378

subject_name: Prednisolone

object_name: adult lymphoma


subject: CHEBI:8378

object_name: lymphoma


subject: CHEBI:8378

object_name: pediatric lymphoma


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: PUBCHEM.COMPOUND:152165

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:152165

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:152165

object_name: breast cancer


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: inflammatory breast carcinoma


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic


subject: MESH:D012462

object_name: pulmonary non-tuberculous mycobacterial infection


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: glioblastoma


subject: CHEBI:44423

object_name: Childhood Glioblastoma


subject: CHEBI:44423

object_name: adult glioblastoma


subject: CHEBI:44423

object_name: glioma


subject: CHEBI:44423

object_name: malignant glioma


subject: CHEBI:64312

subject_name: Memantine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Malignant pleural effusion


subject: UNII:I031V2H011

object_name: Malignant ascites


subject: UMLS:C1722614

subject_name: Veronate

object_name: Sepsis


subject: UMLS:C1722614

object_name: Sepsis, CTCAE


subject: UMLS:C1722614

object_name: staphylococcal infection


subject: UMLS:C1722614

object_name: Cross Infection


subject: UMLS:C1722614

object_name: candidemia


subject: UNII:DSS3BE2ZXN

subject_name: tusamitamab ravtansine

object_name: childhood neoplasm


subject: UNII:DSS3BE2ZXN

object_name: neoplastic syndrome


subject: UNII:DSS3BE2ZXN

object_name: cancer or benign tumor


subject: UNII:DSS3BE2ZXN

object_name: neoplasm


subject: UMLS:C3896771


subject: UMLS:C3896771


subject: UMLS:C3896771


subject: UMLS:C3896771


subject: CHEBI:681569

subject_name: Clofarabine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265

object_name: acute myeloid leukemia


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:140592

subject_name: Onalespib

object_name: Solid Neoplasm


subject: CHEBI:140592

object_name: Childhood Breast Carcinoma


subject: CHEBI:140592

object_name: breast carcinoma


subject: CHEBI:140592

object_name: breast cancer


subject: UNII:6SN82Y9U73

subject_name: FORODESINE HYDROCHLORIDE

object_name: T-cell leukemia


subject: UMLS:C1997549

subject_name: Forodesine hydrochloride


subject: UMLS:C1175653


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Advanced cancer


subject: CHEBI:46195

object_name: Opioid use, unspecified


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1721684

subject_name: lexatumumab


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:9824461

object_name: Sensory Loss


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Ischemic stroke


subject: CHEBI:39548

object_name: ventilator-associated pneumonia


subject: UNII:F13K378W4L

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: ulcerative colitis


subject: UNII:XCL1K2T28K

object_name: biliary tract cancer


subject: UNII:XCL1K2T28K

object_name: liver carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Rotator Cuff Injuries


subject: CHEBI:60802

object_name: Rotator Cuff Injury, CTCAE


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Bacterial resistance


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: thrombocytopenia


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Hyperhidrosis, CTCAE


subject: PUBCHEM.COMPOUND:86217377

object_name: Hyperhidrosis


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:63631

subject_name: Topiramate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63631

object_name: obesity


subject: CHEBI:63631

object_name: Obesity, CTCAE


subject: CHEBI:63631

object_name: binge eating


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: gastric neoplasm


subject: UMLS:C3641122


subject: UNII:6T4O391P5Y

subject_name: Vactosertib


subject: UNII:9M85GXG84D

subject_name: NERAMEXANE MESYLATE

object_name: Tinnitus, Subjective


subject: UMLS:C2698449

subject_name: Neramexane Mesylate


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:192614

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) refractory


subject: PUBCHEM.COMPOUND:42602260

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) refractory


subject: PUBCHEM.COMPOUND:42602260

object_name: Lymphoblastic lymphoma (Precursor B-lymphoblastic lymphoma/leukaemia) recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: acute lymphoblastic leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:94518

object_name: Postoperative Hemorrhage, CTCAE


subject: UMLS:C3896901

object_name: glioma


subject: UMLS:C3896901

object_name: malignant glioma


subject: MESH:C527545

subject_name: hMG-IBSA

object_name: infertility


subject: GTOPDB:8313

subject_name: talazoparib

object_name: metastatic prostate carcinoma


subject: CHEBI:39585

subject_name: Carbidopa

object_name: mood (physical finding)


subject: CHEBI:39585

object_name: Sedation complication


subject: UMLS:C3541397

subject_name: oil ingredients


subject: UMLS:C3541397

object_name: Cognitive impairment


subject: UMLS:C3541397


subject: MESH:D009821

subject_name: Oils


subject: MESH:D009821


subject: MESH:D009821


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: schizophrenia


subject: CHEBI:10119

object_name: schizoaffective disorder


subject: CHEBI:10119

object_name: schizophrenia 18


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: leprosy


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: Hay fever


subject: PUBCHEM.COMPOUND:444033

object_name: Atopic rhinitis


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: renal carcinoma


subject: CHEBI:85994

object_name: kidney neoplasm


subject: CHEBI:85994

object_name: kidney cancer


subject: CHEBI:85994

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:85994

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:85995

subject_name: lenvatinib mesylate


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: GTOPDB:9589

subject_name: enoblituzumab

object_name: nephroblastoma


subject: GTOPDB:9589

object_name: Wilms tumor


subject: GTOPDB:9589

object_name: childhood kidney Wilms tumor


subject: GTOPDB:9589

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: GTOPDB:9589

object_name: desmoplastic small round cell tumor


subject: GTOPDB:9589

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: GTOPDB:9589

object_name: Ewing sarcoma


subject: GTOPDB:9589

object_name: Adult Rhabdomyosarcoma


subject: GTOPDB:9589

object_name: rhabdomyosarcoma


subject: GTOPDB:9589

object_name: Childhood Rhabdomyosarcoma


subject: GTOPDB:9589

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: GTOPDB:9589

object_name: Childhood Neuroblastoma


subject: GTOPDB:9589

object_name: neuroblastoma


subject: GTOPDB:9589

object_name: pediatric osteosarcoma


subject: GTOPDB:9589

object_name: Osteosarcoma


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: UNII:XN7MM8XG2M

subject_name: Clascoterone

object_name: acne


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: prostate adenocarcinoma


subject: CHEBI:80489

subject_name: desmethylxanthohumol

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:80489

object_name: metabolic syndrome X


subject: CHEBI:66331

subject_name: Xanthohumol


subject: CHEBI:66331


subject: CHEBI:7459

subject_name: Naloxone

object_name: hypogonadotropic hypogonadism


subject: CHEBI:7459

object_name: Klinefelter syndrome


subject: CHEBI:7459

object_name: Decreased serum testosterone concentration


subject: UMLS:C0003015

object_name: Hyperoxaluria


subject: UMLS:C3536837

subject_name: Angiotensin Converting Enzyme Inhibitor [EPC]


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0815017

subject_name: Angiotensin Receptor Antagonists


subject: DRUGBANK:DB18274

object_name: cystic fibrosis


subject: CHEBI:30145

subject_name: lithium atom

object_name: Cancer patients and suicide and depression


subject: CHEBI:30145

object_name: Depressed - symptom


subject: CHEBI:30145

object_name: Depression, CTCAE


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: diphtheria


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: tetanus


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: age-related macular degeneration


subject: CHEBI:71940

subject_name: Tadalafil

object_name: cardiomyopathy


subject: CHEBI:71940

object_name: kidney failure


subject: CHEBI:73501

subject_name: Glu-Phe-Val

object_name: HIV-1 infection


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PUBCHEM.COMPOUND:2269

object_name: childhood onset asthma


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: hypopharyngeal carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: hypopharynx cancer


subject: CHEBI:31898

subject_name: Nedaplatin


subject: CHEBI:31898


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UMLS:C5207052


subject: CHEMBL.COMPOUND:CHEMBL2107863

subject_name: RINDOPEPIMUT

object_name: Pontine Tumors


subject: CHEMBL.COMPOUND:CHEMBL2107863

object_name: brainstem neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2107863

object_name: brain cancer


subject: CHEMBL.COMPOUND:CHEMBL2107863

object_name: brain neoplasm


subject: UMLS:C3181262

subject_name: rindopepimut


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UMLS:C3181262


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: type 2 diabetes mellitus


subject: UNII:71M78END5S

object_name: Inflammatory Response


subject: UNII:71M78END5S

object_name: insulin sensitivity/resistance


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:1805

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Refractory Acute Leukemia of Ambiguous Lineage


subject: PUBCHEM.COMPOUND:596

object_name: acute leukemia of ambiguous lineage in relapse


subject: PUBCHEM.COMPOUND:596

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Refractory acute myeloid leukemia


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:44210114

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:44210114

object_name: Mixed bipolar affective disorder


subject: PUBCHEM.COMPOUND:44210114

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:44210114

object_name: Organic mood disorder


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: Plasma cell myeloma refractory


subject: CHEBI:15698

object_name: Relapse multiple myeloma


subject: GTOPDB:12889

subject_name: elranatamab


subject: GTOPDB:12889


subject: UNII:L0HR9A577V

subject_name: Elranatamab


subject: UNII:L0HR9A577V


subject: UMLS:C4687515


subject: UMLS:C4687515


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C4086994

object_name: pancreatic neoplasm


subject: UMLS:C4086994

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4086994

object_name: malignant pancreatic neoplasm


subject: UMLS:C4086994

object_name: pancreatic adenocarcinoma


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: meningococcal infection


subject: UMLS:C3152625

object_name: pneumococcal infection


subject: UMLS:C3152625

object_name: HIV infection


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine


subject: MESH:C414006


subject: MESH:C414006


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Dyslipidemia


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C4310001

object_name: hepatitis C


subject: UMLS:C4310001

object_name: chronic hepatitis C virus infection


subject: UMLS:C4310001


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3897088

object_name: acute myeloid leukemia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: atopic eczema


subject: CHEBI:9570

subject_name: Thiotepa

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:9570

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:9570

object_name: childhood myelodysplastic syndrome


subject: CHEBI:9570

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:9570

object_name: non-Hodgkin lymphoma


subject: CHEBI:9570

object_name: Hodgkin Disease


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Menorrhagia


subject: CHEBI:231594

object_name: Menorrhagia, CTCAE


subject: CHEBI:9654

subject_name: Trazodone

object_name: obstructive sleep apnea syndrome


subject: CHEBI:9654

object_name: mild neurocognitive disorder


subject: CHEBI:9654

object_name: mild cognitive impairment


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: cancer


subject: CHEBI:46195

object_name: neoplasm


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:4511

subject_name: Dicloxacillin

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: pulmonary fibrosis


subject: PUBCHEM.COMPOUND:135423438

object_name: Pulmonary Fibrosis, CTCAE


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: UMLS:C1879771


subject: CHEBI:85164


subject: CHEBI:85164


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malignant glioma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: liver carcinoma


subject: CHEBI:72317

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:72317

object_name: Recurrent Carcinoma


subject: UMLS:C1579410

subject_name: Nucleoside Analogs

object_name: chronic hepatitis B virus infection


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: CHEBI:2704

subject_name: Anastrozole

object_name: invasive breast carcinoma


subject: CHEBI:2704

object_name: Multifocal breast carcinoma


subject: CHEBI:2704

object_name: Multicentric Breast Carcinoma


subject: CHEBI:2704

object_name: synchronous bilateral breast carcinoma


subject: CHEBI:2704

object_name: ductal breast carcinoma in situ


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Heartburn


subject: CHEBI:59773

object_name: Aspiration


subject: CHEBI:59773

object_name: interstitial lung disease 1


subject: CHEBI:59773

object_name: interstitial lung disease 2


subject: UMLS:C2350056

object_name: coronary stenosis


subject: CHEBI:31705

subject_name: Iodixanol


subject: PUBCHEM.COMPOUND:3734

subject_name: Iopamidol


subject: UMLS:C5772993

object_name: multiple sclerosis


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: T-Cell Lymphoma


subject: CHEBI:91397

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:349552KRHK

subject_name: Simendan

object_name: acute kidney failure


subject: UNII:349552KRHK

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: UMLS:C0879595

subject_name: Selective Cytokine Inhibitory Drug CC-1088

object_name: Myelodysplasia


subject: UMLS:C0879595

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0879595

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0879595

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: Recurrent Rectal Cancer


subject: UMLS:C4287710

object_name: rectal carcinoma


subject: UMLS:C4287710

object_name: rectal cancer


subject: UMLS:C4287710

object_name: Childhood Rectal Carcinoma


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Depressed mood


subject: CHEBI:31236

object_name: Cancer patients and suicide and depression


subject: CHEBI:31236

object_name: Depressed - symptom


subject: CHEBI:31236

object_name: Depression, CTCAE


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: pediatric osteosarcoma


subject: UMLS:C4549198

object_name: respiratory syncytial virus infectious disease


subject: PR:000013518

subject_name: pyrin domain-containing protein 1

object_name: acute myeloid leukemia


subject: CHEBI:2549

subject_name: Albuterol

object_name: glycogen storage disease II


subject: UMLS:C5706405

subject_name: Bcl-2 Inhibitor ABBV-453

object_name: plasma cell myeloma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Compulsion


subject: UMLS:C0021745

subject_name: interferon type II

object_name: Friedreich ataxia


subject: UMLS:C0021745

object_name: Friedreich ataxia 1


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: invasive breast carcinoma


subject: UNII:52CMI0WC3Y

object_name: breast adenocarcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C2981820

object_name: Solid Neoplasm


subject: CHEBI:145373

subject_name: Pexidartinib


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:74030550

object_name: Sensory Loss


subject: UNII:7C17NQF03M

subject_name: Sevuparin

object_name: sickle cell disease


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Nerve Pain


subject: PUBCHEM.COMPOUND:71300864

object_name: heart failure


subject: PUBCHEM.COMPOUND:71300864

object_name: Heart Failure, CTCAE


subject: CHEBI:74947

subject_name: Thalidomide

object_name: nephroblastoma


subject: CHEBI:74947

object_name: Wilms tumor


subject: CHEBI:74947

object_name: childhood kidney Wilms tumor


subject: CHEBI:74947

object_name: primitive neuroectodermal tumor


subject: CHEBI:74947

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:74947

object_name: rhabdomyosarcoma


subject: CHEBI:74947

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:74947

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:74947

object_name: Ewing sarcoma


subject: CHEBI:74947

object_name: retinoblastoma


subject: CHEBI:74947

object_name: pediatric osteosarcoma


subject: CHEBI:74947

object_name: Osteosarcoma


subject: CHEBI:74947

object_name: glioma


subject: CHEBI:74947

object_name: malignant glioma


subject: CHEBI:6538

subject_name: Loratadine

object_name: Atopic rhinitis


subject: CHEBI:6538

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: GTOPDB:1160

subject_name: hCG

object_name: paroxysmal familial ventricular fibrillation


subject: GTOPDB:1160

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: UNII:52CMI0WC3Y

object_name: colorectal neoplasm


subject: UMLS:C3827082


subject: UMLS:C4745170

subject_name: Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901


subject: UMLS:C4745171

subject_name: mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:17026

subject_name: Progesterone

object_name: cocaine dependence


subject: CHEBI:17026

object_name: nicotine dependence


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: MESH:D012982

subject_name: Sodium, Dietary

object_name: Irritable heart


subject: UNII:DE79L822UY

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: sinusitis


subject: PUBCHEM.COMPOUND:6912

object_name: Sinusitis, CTCAE


subject: PUBCHEM.COMPOUND:6912

object_name: Rhinosinusitis


subject: PUBCHEM.COMPOUND:6912

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:6912

object_name: Bacterial resistance


subject: PUBCHEM.COMPOUND:6912

object_name: Inflammatory fistula


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:9622

subject_name: Tolterodine

object_name: Urinary Urgency


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: solar skin damage


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:82339

subject_name: Merphalan

object_name: pediatric extraocular retinoblastoma


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: family history of Alzheimer’s disease


subject: UMLS:C0521942

object_name: subjective cognitive decline


subject: UMLS:C0521942

object_name: hypertension


subject: UMLS:C0521942

object_name: Hypertension, CTCAE


subject: UMLS:C3536793

subject_name: Angiotensin 2 Receptor Blocker [EPC]


subject: UMLS:C3536793


subject: UMLS:C3536793


subject: UMLS:C3536793


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:2668


subject: UMLS:C5447493

subject_name: PI3Kdelta/gamma Inhibitor ZX-101A

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5447493

object_name: non-Hodgkin lymphoma


subject: UMLS:C5447493

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5447493

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:681569

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:681569

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:681569

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:681569

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:681569

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:681569

object_name: Adult Acute Promyelocytic Leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:7FY24HE2G3

subject_name: Tanakan


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: lung neoplasm


subject: UMLS:C0338133

subject_name: Gemzar

object_name: non-small cell lung carcinoma


subject: UMLS:C0338133


subject: UMLS:C0338133

object_name: neoplasm


subject: CHEBI:72296

subject_name: Apixaban

object_name: stroke disorder


subject: CHEBI:72296

object_name: Stroke (heart beat)


subject: CHEBI:72296

object_name: Stroke, CTCAE


subject: CHEBI:72296

object_name: Ischemic stroke


subject: CHEBI:72296

object_name: cerebral infarction


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Loss of Chromosome 17p


subject: CHEBI:41879

object_name: chromosome 17p deletion


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: developmental disability


subject: PUBCHEM.COMPOUND:24984318

object_name: intellectual disability


subject: CHEBI:53762

object_name: Hot Flashes, CTCAE


subject: CHEBI:53762

object_name: Hot flashes


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:32315


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: sebaceous adenoma


subject: CHEBI:50730

subject_name: Montelukast

object_name: pertussis


subject: CHEBI:50730

object_name: Whooping cough


subject: CHEBI:50730

object_name: Chronic cough


subject: CHEBI:50730

object_name: Persistent cough


subject: UNII:V5Y646AW8S

object_name: cocaine abuse


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:8499

subject_name: Propranolol


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: cervical polyp


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UMLS:C4329329


subject: CHEBI:33380

subject_name: thulium atom

object_name: myocardial infarction


subject: CHEBI:33380

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:33380

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: CHEBI:5775

subject_name: Hydralazine

object_name: hypertension


subject: CHEBI:5775

object_name: Hypertension, CTCAE


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: CHEBI:15940

subject_name: Niacin

object_name: Hypercholesterolemia


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:135942

subject_name: Laropiprant


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: CHEBI:6121

subject_name: Ketamine

object_name: post-traumatic stress disorder


subject: CHEBI:6121

object_name: Compulsion


subject: CHEMBL.COMPOUND:CHEMBL2109047

subject_name: INTERFERON ALFA-N3

object_name: HIV infection


subject: UMLS:C0718345

subject_name: Alferon N


subject: UMLS:C4763517

object_name: acute myeloid leukemia


subject: CHEBI:17026

subject_name: Progesterone

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:17026

object_name: Recurrent Glioblastoma


subject: CHEBI:17026

object_name: Adult Gliosarcoma


subject: CHEBI:17026

object_name: gliosarcoma


subject: CHEBI:17026

object_name: Childhood Gliosarcoma


subject: CHEBI:188219

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:188219

object_name: obesity


subject: CHEBI:188219

object_name: Obesity, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Skin Abscess


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:231614

subject_name: Nivolumab

object_name: carcinoma


subject: CHEBI:231614

object_name: kidney medullary carcinoma


subject: CHEBI:231614

object_name: collecting duct carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: liver cancer


subject: UNII:5S371K6132

object_name: liver neoplasm


subject: UNII:5S371K6132

object_name: Adult Liver Carcinoma


subject: MESH:D023321

subject_name: Poliovirus Vaccines

object_name: poliomyelitis


subject: PUBCHEM.COMPOUND:60787

subject_name: Saquinavir

object_name: HIV infection


subject: CHEBI:197107

subject_name: Bafetinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:197107

object_name: acute lymphoblastic leukemia


subject: UMLS:C1831933


subject: UMLS:C1831933


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Infant, Premature, Diseases


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: metastatic prostate carcinoma


subject: UNII:6XC1PAD3KF

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: autism


subject: CHEBI:91514

subject_name: Mebeverine

object_name: bowel dysfunction


subject: CHEBI:31498

subject_name: Simethicone


subject: UMLS:C3537001

subject_name: ALT 711

object_name: congestive heart failure


subject: UMLS:C3537001

object_name: pulmonary edema


subject: UMLS:C3537001

object_name: Pulmonary Edema, CTCAE


subject: UMLS:C3537001

object_name: Dyspnea


subject: UMLS:C3537001

object_name: Dyspnea, CTCAE


subject: UMLS:C3537001

object_name: cardiovascular surgery result: dyspnea


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: adult lymphoma


subject: UNII:2AW48LAZ4I

object_name: lymphoma


subject: UNII:2AW48LAZ4I

object_name: pediatric lymphoma


subject: UNII:2AW48LAZ4I

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:2AW48LAZ4I

object_name: lymphoproliferative syndrome


subject: UNII:2AW48LAZ4I

object_name: small intestine cancer


subject: UNII:2AW48LAZ4I

object_name: small intestine carcinoma


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: biliary tract cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: liver carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:50692

subject_name: Mifepristone

object_name: endogenous depression


subject: CHEBI:50692

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:54676860

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: bone sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:54676860

object_name: Unresectable Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:54676860

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22651


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:167715


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: lung cancer


subject: CHEBI:72317

object_name: lung neoplasm


subject: CHEBI:72317

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:137441492

subject_name: ZASOCITINIB

object_name: Acne inversa


subject: DRUGBANK:DB19278

subject_name: Zasocitinib


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: chronic obstructive pulmonary disease


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: hyperlipidemia


subject: CHEBI:39548

object_name: hyperlipoproteinemia


subject: CHEBI:39548

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:39548

object_name: Serum lipids high (finding)


subject: CHEBI:39548

object_name: hypertension


subject: CHEBI:39548

object_name: Hypertension, CTCAE


subject: CHEBI:136044

subject_name: Fimasartan


subject: CHEBI:136044


subject: CHEBI:136044


subject: CHEBI:136044


subject: CHEBI:132975

subject_name: Grazoprevir

object_name: Infection of transplanted kidney


subject: CHEBI:132975

object_name: Infection of liver transplant


subject: CHEBI:132967

subject_name: Elbasvir

object_name: hepatitis C


subject: CHEBI:132967

object_name: chronic hepatitis C virus infection


subject: CHEBI:132967


subject: CHEBI:132967


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: coronary artery disorder


subject: CHEBI:63005

object_name: coronary atherosclerosis


subject: UMLS:C5577555

subject_name: Opdualag

object_name: basal cell carcinoma


subject: UMLS:C5577555

object_name: skin basal cell carcinoma


subject: UNII:QX0ONY0O9T

subject_name: SIGVOTATUG VEDOTIN

object_name: head and neck squamous cell carcinoma


subject: UNII:QX0ONY0O9T


subject: UNII:QX0ONY0O9T

object_name: esophageal squamous cell carcinoma


subject: UNII:QX0ONY0O9T

object_name: non-small cell lung carcinoma


subject: UNII:QX0ONY0O9T

object_name: esophageal adenocarcinoma


subject: UNII:QX0ONY0O9T

object_name: gastric adenocarcinoma


subject: UMLS:C5908938

subject_name: Sigvotatug vedotin


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: anemia


subject: UNII:AHU547PI9H

object_name: Anemia, CTCAE


subject: UNII:AHU547PI9H

object_name: female reproductive organ cancer


subject: CHEBI:60802

subject_name: ropivacaine

object_name: chronic bronchitis


subject: CHEBI:60802

object_name: bronchitis


subject: CHEBI:60802

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:60802

object_name: obesity


subject: CHEBI:60802

object_name: Obesity, CTCAE


subject: CHEBI:63632

subject_name: Topotecan

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5666968

subject_name: KRAS G12C Inhibitor MK-1084

object_name: Hepatic impairment


subject: CHEBI:3441

subject_name: Carvedilol

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:3441

object_name: pulmonary hypertension


subject: CHEBI:3441

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:3441

object_name: pulmonary arterial hypertension


subject: UMLS:C5784795

subject_name: PD-L1 Inhibitor INCB099318

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5784795

object_name: skin squamous cell carcinoma


subject: UMLS:C5784795

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5784795

object_name: sarcomatoid renal cell carcinoma


subject: UMLS:C5784795

object_name: squamous cell carcinoma of penis


subject: UMLS:C5784795

object_name: nasopharyngeal carcinoma


subject: UMLS:C5784795

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5784795

object_name: trabecular adenocarcinoma


subject: UMLS:C5784795

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5784795

object_name: cervical cancer


subject: UMLS:C5784795

object_name: cervical carcinoma


subject: UMLS:C5784795

object_name: anal margin carcinoma


subject: UMLS:C5784795

object_name: anal carcinoma


subject: UMLS:C5784795

object_name: Mesothelioma


subject: UMLS:C5784795

object_name: mesothelial neoplasm


subject: UMLS:C5784795

object_name: malignant mesothelioma


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Childhood Breast Carcinoma


subject: UNII:1C6V77QF41

object_name: breast carcinoma


subject: UNII:1C6V77QF41

object_name: breast cancer


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:231614

subject_name: Nivolumab

object_name: High grade glioma


subject: CHEBI:231614

object_name: malignant glioma


subject: CHEBI:231614

object_name: glioma


subject: CHEBI:231614

object_name: brain cancer


subject: CHEBI:231614

object_name: brain neoplasm


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:74698

subject_name: Met-Arg


subject: CHEBI:74698


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: PR:000011407


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: pulmonary hypertension


subject: CHEBI:135949

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:135949

object_name: Heart failure with normal ejection fraction


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: hepatitis A


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:41XGO0VS1U

object_name: liver carcinoma


subject: UMLS:C0242708

subject_name: Antirheumatic Drugs, Disease-Modifying

object_name: rheumatoid arthritis


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Pick Complex


subject: CHEBI:76016

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:76016

object_name: frontotemporal dementia


subject: CHEBI:76016

object_name: Pick disease


subject: CHEBI:76016

object_name: behavioral variant of frontotemporal dementia


subject: CHEBI:76016

object_name: Frontotemporal dementia (FTD)


subject: CHEBI:76016

object_name: Frontotemporal degeneration


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Cervical intraepithelial neoplasia grade 2


subject: CHEBI:36704

object_name: cervical intraepithelial neoplasia grade 2/3


subject: CHEBI:36704

object_name: High Grade Cervical Intraepithelial Neoplasia


subject: CHEBI:36704

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:139072

object_name: endogenous depression


subject: CHEBI:139072

object_name: major depressive disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: UMLS:C5446534

subject_name: Gimistotug

object_name: melanoma


subject: UMLS:C5446534

object_name: urothelial carcinoma


subject: UMLS:C5446534

object_name: transitional cell carcinoma


subject: UMLS:C5446534

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5446534

object_name: clear cell renal carcinoma


subject: UMLS:C5446534

object_name: renal cell adenocarcinoma


subject: UMLS:C5446534

object_name: renal cell carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: gastroesophageal adenocarcinoma


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: GTOPDB:12347

subject_name: penpulimab


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: CHEBI:6456

subject_name: Lidocaine

object_name: migraine


subject: CHEBI:6456

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:35341


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:2735

object_name: autism


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEMBL.COMPOUND:CHEMBL2108572

subject_name: BALUGRASTIM

object_name: Solid Neoplasm


subject: UMLS:C3871462

subject_name: balugrastim


subject: CHEMBL.COMPOUND:CHEMBL2108029

subject_name: ERTUMAXOMAB

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108029

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108029

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2108029

object_name: breast neoplasm


subject: UMLS:C1723386

subject_name: ertumaxomab


subject: UMLS:C1723386


subject: UMLS:C1723386


subject: UMLS:C1723386


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:95165

object_name: esophageal squamous cell carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: GTOPDB:12347


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Heart Injuries


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C4053669

object_name: Drug Interactions


subject: UMLS:C4053669

object_name: Adverse drug interaction


subject: UMLS:C3641866


subject: UMLS:C3641866


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:231614

subject_name: Nivolumab

object_name: malignant epithelial tumor of ovary


subject: UMLS:C2346820


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: ovarian carcinoma


subject: UNII:HX101E7L6S


subject: UMLS:C0664206

subject_name: Ovarex


subject: UMLS:C0664206


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: immune system disorder


subject: CHEBI:4026

object_name: demyelinating disease


subject: CHEBI:4026

object_name: nervous system disorder


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:31824

subject_name: Mesna

object_name: multiple sclerosis


subject: CHEBI:31824

object_name: Autoimmunity


subject: CHEBI:31824

object_name: autoimmune disorder of the nervous system


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab


subject: UNII:A10SJL62JY


subject: UNII:A10SJL62JY


subject: UNII:A10SJL62JY


subject: UNII:A10SJL62JY


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: prostate carcinoma


subject: CHEBI:63605

object_name: prostate cancer


subject: CHEBI:144094

subject_name: bicalutamide


subject: CHEBI:144094


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: pediatric osteosarcoma


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168

object_name: Osteosarcoma


subject: CHEBI:229526

subject_name: Sparsentan

object_name: lipoid nephrosis


subject: CHEBI:229526

object_name: focal segmental glomerulosclerosis


subject: CHEBI:229526

object_name: IgA Nephropathy


subject: CHEBI:229526

object_name: Alport syndrome


subject: CHEBI:229526

object_name: IgA vasculitis


subject: UMLS:C5543952

object_name: Parkinson disease


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: renal cell carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: UMLS:C2703114


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:24999143

subject_name: artefenomel

object_name: malaria


subject: UMLS:C3181201


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: plasma cell myeloma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: myeloproliferative neoplasm


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368

object_name: leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: childhood leukemia


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:A7YT618XBV

subject_name: AS03 adjuvant

object_name: influenza


subject: UNII:A7YT618XBV

object_name: swine influenza


subject: UNII:A7YT618XBV

object_name: avian influenza


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: UMLS:C2604127

subject_name: DCFBC F-18

object_name: prostate carcinoma


subject: UMLS:C2604127

object_name: prostate cancer


subject: UMLS:C5238421

subject_name: PARP Inhibitor NMS-03305293

object_name: glioblastoma


subject: UMLS:C5238421

object_name: Childhood Glioblastoma


subject: UMLS:C5238421

object_name: adult glioblastoma


subject: UMLS:C5238421

object_name: Diffuse Glioma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Advanced bladder cancer


subject: UMLS:C3896914


subject: UMLS:C0722196

subject_name: Nutropin AQ

object_name: Congenital IGHD


subject: UMLS:C0722196

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C0722196

object_name: septooptic dysplasia


subject: UMLS:C0722196

object_name: hypopituitarism


subject: UMLS:C0722196

object_name: Hypopituitarism, CTCAE


subject: UMLS:C4527230

subject_name: Zirconium (89Zr) crefmirlimab berdoxam

object_name: adult lymphoma


subject: UMLS:C4527230

object_name: lymphoma


subject: UMLS:C4527230

object_name: pediatric lymphoma


subject: UMLS:C4527230

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: lung cancer


subject: UNII:5S371K6132

object_name: lung neoplasm


subject: UNII:5S371K6132

object_name: lung carcinoma


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Leukemia - acute myeloid leukemia (AML)


subject: UMLS:C1831824

object_name: castration-resistant prostate carcinoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Complications of Diabetes Mellitus


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:27470

subject_name: Folic acid

object_name: Reduced blood folate concentration


subject: CHEBI:6121

subject_name: Ketamine

object_name: pervasive developmental disorder


subject: CHEBI:6121

object_name: autism


subject: CHEBI:6121

object_name: autism spectrum disorder


subject: UMLS:C5206828

subject_name: Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP

object_name: Adult Solid Neoplasm


subject: UMLS:C5206829

subject_name: MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP


subject: UNII:3HO3IZ2ILX

object_name: chronic kidney disease


subject: UNII:3HO3IZ2ILX

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Surgical procedure finding


subject: CHEBI:94518

object_name: cancer


subject: CHEBI:94518

object_name: neoplasm


subject: CHEBI:50730

subject_name: Montelukast


subject: CHEBI:50730

object_name: SARS (Disease)


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: primary central nervous system lymphoma


subject: UNII:WJA5UO9E10

object_name: non-Hodgkin lymphoma


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEMBL.COMPOUND:CHEMBL4594612

subject_name: BEPRANEMAB

object_name: progressive supranuclear palsy


subject: UMLS:C5420866

subject_name: Bepranemab


subject: PUBCHEM.COMPOUND:14326905

object_name: Small intestine carcinoma stage IV


subject: PUBCHEM.COMPOUND:14326905

object_name: Small intestine carcinoma stage III


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Small Intestinal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Small Intestinal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IVA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IVB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage II Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIA Esophagus Carcinoma


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIB Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Advanced Bile Duct Carcinoma


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:14326905

object_name: Malignant neoplasm of stomach stage III


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IVB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IVA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIC Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Liver Cancer


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Hepatic cancer stage IVA


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IVB Liver Cancer


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIB Adult Liver Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIC Adult Liver Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Liver Cancer


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage IIIA Adult Liver Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14326905

object_name: Stage III Adult Liver Cancer AJCC v7


subject: UNII:3HX21A3SQF

subject_name: Ropidoxuridine

object_name: Small intestine carcinoma stage IV


subject: UNII:3HX21A3SQF

object_name: Small intestine carcinoma stage III


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Small Intestinal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Small Intestinal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage II Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIA Esophagus Carcinoma


subject: UNII:3HX21A3SQF

object_name: Stage IIB Esophageal Carcinoma


subject: UNII:3HX21A3SQF

object_name: Stage III Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Advanced Bile Duct Carcinoma


subject: UNII:3HX21A3SQF

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:3HX21A3SQF

object_name: Malignant neoplasm of stomach stage III


subject: UNII:3HX21A3SQF

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Gastric Carcinoma


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Gastric Carcinoma


subject: UNII:3HX21A3SQF

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:3HX21A3SQF

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:3HX21A3SQF

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: UNII:3HX21A3SQF

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:3HX21A3SQF

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: UNII:3HX21A3SQF

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IV Liver Cancer


subject: UNII:3HX21A3SQF

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Hepatic cancer stage IVA


subject: UNII:3HX21A3SQF

object_name: Stage IVB Liver Cancer


subject: UNII:3HX21A3SQF

object_name: Stage IIIB Adult Liver Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage IIIC Adult Liver Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage III Liver Cancer


subject: UNII:3HX21A3SQF

object_name: Stage IIIA Adult Liver Cancer AJCC v7


subject: UNII:3HX21A3SQF

object_name: Stage III Adult Liver Cancer AJCC v7


subject: UMLS:C0950069

subject_name: Kudzu

object_name: alcohol consumption (history)


subject: UMLS:C3540829

subject_name: Pueraria montana var. lobata whole extract


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: malignant pleural mesothelioma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UNII:18EAY4870E

subject_name: MIPOMERSEN SODIUM

object_name: Hypercholesterolemia


subject: UNII:18EAY4870E

object_name: hypercholesterolemia, familial, 1


subject: UNII:18EAY4870E

object_name: hyperlipidemia


subject: UNII:18EAY4870E

object_name: familial hypercholesterolemia


subject: UNII:18EAY4870E

object_name: Dyslipidemia


subject: UNII:18EAY4870E

object_name: inherited lipid metabolism disorder


subject: UNII:18EAY4870E

object_name: hyperlipoproteinemia


subject: UNII:18EAY4870E

object_name: inborn errors of metabolism


subject: UNII:18EAY4870E

object_name: Fetal anomaly


subject: UNII:18EAY4870E

object_name: genetic disease


subject: UNII:18EAY4870E

object_name: Neonatal disorder


subject: UNII:18EAY4870E

object_name: metabolic disease


subject: UNII:9GJ8S4GU0M

subject_name: Mipomersen


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: coronary artery disorder


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: lung cancer


subject: CHEBI:91368

object_name: lung neoplasm


subject: CHEBI:91368

object_name: lung carcinoma


subject: CHEBI:4953

subject_name: Exemestane

object_name: Carcinoma breast stage IV


subject: CHEBI:6427

subject_name: Leuprolide


subject: UMLS:C4331032

subject_name: Cx-072 probody

object_name: Childhood Solid Neoplasm


subject: UMLS:C4331032

object_name: Adult Solid Neoplasm


subject: UMLS:C4331032

object_name: Solid Neoplasm


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: spinal cord injury


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: carcinoma of esophagus


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: acute coronary syndrome


subject: UMLS:C2981814

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:EXL0L74IKU

object_name: Acute HIV infection


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: Diabetes


subject: CHEBI:85662

object_name: diabetes mellitus


subject: CHEBI:85662

object_name: Steroid-induced diabetes


subject: CHEBI:85662

object_name: Hyperglycemia steroid-induced


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: UMLS:C0876064


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Malignant obstetric neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:5PKM8P0G5I

subject_name: Vonicog alfa

object_name: von Willebrand disease 3


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: ankylosing spondylitis


subject: UNII:FN12T66RMN

subject_name: EFPREZIMOD ALFA


subject: UMLS:C4287663


subject: UNII:71V0XKJ0WZ

subject_name: PEGTEOGRASTIM

object_name: mantle cell lymphoma


subject: UMLS:C4288415

subject_name: Pegteograstim


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:10033

subject_name: Warfarin

object_name: interstitial lung disease 1


subject: CHEBI:10033

object_name: interstitial lung disease 2


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: prostate carcinoma


subject: CHEBI:168243

object_name: prostate cancer


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:38940

subject_name: Sunitinib

object_name: type C thymoma


subject: CHEBI:38940

object_name: thymoma type B3


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: skin squamous cell carcinoma


subject: GTOPDB:13396

object_name: cutaneous squamous cell carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5446618

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5446618

object_name: non-Hodgkin lymphoma


subject: UMLS:C5446618

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5446618

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:3766

subject_name: Clozapine

object_name: psychosis


subject: CHEBI:149601

subject_name: Bempedoic acid

object_name: Hypercholesterolemia


subject: CHEBI:149601

object_name: HMG COA reductase inhibitor adverse reaction


subject: CHEBI:149601

object_name: arteriosclerosis disorder


subject: CHEBI:149601

object_name: atherosclerosis


subject: CHEBI:151315

subject_name: Heparin

object_name: respiratory failure


subject: CHEBI:151315

object_name: Respiratory Failure, CTCAE


subject: CHEBI:38940

object_name: carcinoid tumor


subject: CHEBI:6456

subject_name: Lidocaine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:6456

object_name: obesity


subject: CHEBI:6456

object_name: Obesity, CTCAE


subject: CHEBI:221840

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:221840

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:221840

object_name: metastatic melanoma


subject: CHEBI:221840

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: myeloproliferative neoplasm


subject: DRUGBANK:DB17293

object_name: essential thrombocythemia


subject: DRUGBANK:DB17293

object_name: myelofibrosis


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: GTOPDB:5070

subject_name: LIGHT

object_name: Chronic ulcer of lower extremity


subject: GTOPDB:5070

object_name: Wound healed (finding)


subject: CHEBI:30212

subject_name: photon


subject: CHEBI:30212


subject: PR:000002222

subject_name: tumor necrosis factor ligand superfamily member 14


subject: PR:000002222


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Acute Pain


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:68596

subject_name: alpha-Asp-Leu

object_name: triple-negative breast carcinoma


subject: CHEBI:68596

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1720919

subject_name: Zostavax

object_name: herpes zoster


subject: CHEBI:71940

subject_name: Tadalafil

object_name: chronic obstructive pulmonary disease


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Ultrafiltration failure


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: PUBCHEM.COMPOUND:3222


subject: CHEBI:4784

subject_name: Enalapril


subject: MESH:D003069

subject_name: Coffee

object_name: Caffeine-related disorder


subject: MESH:C558464

object_name: herpes labialis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Childhood Breast Carcinoma


subject: UNII:3A58010674

object_name: breast carcinoma


subject: UNII:3A58010674

object_name: breast cancer


subject: UNII:3A58010674


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C3154258

subject_name: Gamunex-C

object_name: Corneal pannus


subject: UMLS:C3154258

object_name: Corneal graft failure


subject: UNII:01OUW6MA4L

subject_name: HYLAN G-F 20

object_name: osteoarthritis


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Unresectable Hepatocellular Carcinoma